Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lap… Read more
Treace Medical Concepts Inc (TMCI) - Total Assets
Latest total assets as of September 2025: $196.59 Million USD
Based on the latest financial reports, Treace Medical Concepts Inc (TMCI) holds total assets worth $196.59 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Treace Medical Concepts Inc - Total Assets Trend (2019–2024)
This chart illustrates how Treace Medical Concepts Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Treace Medical Concepts Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Treace Medical Concepts Inc's total assets of $196.59 Million consist of 74.4% current assets and 25.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.2% |
| Accounts Receivable | $40.80 Million | 18.8% |
| Inventory | $39.26 Million | 18.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $8.07 Million | 3.7% |
| Goodwill | $12.81 Million | 5.9% |
Asset Composition Trend (2019–2024)
This chart illustrates how Treace Medical Concepts Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Treace Medical Concepts Inc's current assets represent 74.4% of total assets in 2024, a decrease from 96.1% in 2019.
- Cash Position: Cash and equivalents constituted 5.2% of total assets in 2024, down from 40.9% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 18.8% of total assets.
Treace Medical Concepts Inc Competitors by Total Assets
Key competitors of Treace Medical Concepts Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
Treace Medical Concepts Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Treace Medical Concepts Inc generates 0.96x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Treace Medical Concepts Inc is currently not profitable relative to its asset base.
Treace Medical Concepts Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.37 | 4.12 | 3.53 |
| Quick Ratio | 2.36 | 2.98 | 2.86 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $97.09 Million | $ 119.34 Million | $ 29.38 Million |
Treace Medical Concepts Inc - Advanced Valuation Insights
This section examines the relationship between Treace Medical Concepts Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.33 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | -13.8% |
| Total Assets | $217.09 Million |
| Market Capitalization | $64.07 Million USD |
Valuation Analysis
Below Book Valuation: The market values Treace Medical Concepts Inc's assets below their book value (0.30 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Treace Medical Concepts Inc's assets decreased by 13.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Treace Medical Concepts Inc (2019–2024)
The table below shows the annual total assets of Treace Medical Concepts Inc from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $217.09 Million | -13.82% |
| 2023-12-31 | $251.91 Million | +58.41% |
| 2022-12-31 | $159.02 Million | +12.93% |
| 2021-12-31 | $140.82 Million | +236.84% |
| 2020-12-31 | $41.81 Million | +40.69% |
| 2019-12-31 | $29.72 Million | -- |